10-Q: LivePerson Q3: Revenue Declines Amid Restructuring, Debt Exchange

LivePerson reports a significant revenue decline in Q3 2025, alongside ongoing restructuring efforts and a complex debt exchange, impacting financial stability.

Summary

• Revenue decreased by 19% to $60.154 million for the three months ended September 30, 2025, compared to $74.244 million in the prior year period.
• For the nine months ended September 30, 2025, revenue decreased by 23% to $184.454 million, down from $239.268 million in the comparable period of 2024.
• The company reported net income of $8.711 million for Q3 2025, a significant improvement from a net loss of $28.309 million in Q3 2024, primarily driven by a gain on troubled debt restructuring.
• A net loss of $21.132 million was recorded for the nine months ended September 30, 2025, compared to a net loss of $22.145 million for the same period in 2024.
• A new restructuring plan (2025 Restructuring Plan) was initiated, resulting in $9.312 million in costs for Q3 2025 and $11.178 million for the nine months ended September 30, 2025.
• The company consummated a troubled debt restructuring on September 12, 2025, exchanging $341.1 million of 2026 Notes for $45.0 million in cash, $115.0 million in Second Lien Notes, 3,555,596 shares of common stock, and 26,551 shares of Series B Preferred Stock, recognizing a gain of $27.7 million.
• Cash and cash equivalents decreased by $76.576 million to $106.661 million as of September 30, 2025, from $183.237 million at December 31, 2024.
• Average Annual Revenue Per Enterprise and Mid-market Customer (ARPC) increased to approximately $665,000 as of September 30, 2025, from $630,000 as of September 30, 2024.
• Revenue retention for enterprise and mid-market customers was approximately 80% in Q3 2025, which is below the target range of 105% to 115%.
• A 1-for-15 reverse stock split was effected on October 13, 2025, to regain compliance with Nasdaq's minimum bid price requirement.

Sentiment

Score: 3

Explanation: While the company reported net income in Q3 due to a significant debt restructuring gain and is actively addressing financial stability through restructuring and a reverse stock split, the underlying operational performance shows substantial revenue decline, poor customer retention, and increased operating costs. The ongoing legal challenges and Nasdaq compliance issues contribute to a negative outlook, indicating deep financial instability despite mitigating actions.

Positives

• Reported net income of $8.711 million for the three months ended September 30, 2025, compared to a net loss of $28.309 million in the prior year period.
• Achieved a $27.7 million gain on troubled debt restructuring, which contributed significantly to the Q3 2025 net income.
• Average Annual Revenue Per Enterprise and Mid-market Customer (ARPC) increased to $665,000 as of September 30, 2025, from $630,000 as of September 30, 2024.
• General and administrative expenses decreased by 38% in Q3 2025 and 44% for the nine months ended September 30, 2025, partly due to a $10.1 million decrease in bad debt expense for the nine-month period.
• Total stockholders' equity improved from a deficit of $67.316 million at December 31, 2024, to a deficit of $22.050 million at September 30, 2025.

Negatives

• Total revenue decreased by 19% in Q3 2025 and 23% for the nine months ended September 30, 2025, primarily due to customer cancellations and downsells.
• Revenue retention for enterprise and mid-market customers was approximately 80% in Q3 2025, significantly below the target range of 105% to 115%.
• Net cash used in operating activities increased to $20.781 million for the nine months ended September 30, 2025, from $12.015 million in the comparable period of 2024.
• Cash and cash equivalents decreased by $76.576 million from December 31, 2024, to September 30, 2025.
• Restructuring costs increased by 543% to $9.312 million in Q3 2025 and by 42% to $11.178 million for the nine months ended September 30, 2025.
• Interest expense increased by 42% to $8.113 million in Q3 2025 and by 178% to $23.457 million for the nine months ended September 30, 2025.
• The company continues to have an accumulated deficit of $1,012.393 million as of September 30, 2025.
• Customer uncertainty regarding financial stability and broader macroeconomic factors are extending enterprise buying cycles for high-value AI solutions, impacting revenue.
• The company's common stock required a 1-for-15 reverse stock split to regain compliance with Nasdaq's minimum bid price requirement, often a sign of underlying financial distress.

Risks

• Failure to comply with Nasdaq Global Select Market continued listing requirements, including the minimum bid price, financial, and corporate governance standards, could result in delisting.
• Delisting from Nasdaq would negatively affect the share price, trading volume, and liquidity of common stock, and could trigger a 'fundamental change' under debt indentures, requiring repurchase of outstanding notes.
• The company cannot assure that the reverse stock split will stabilize the market price, improve liquidity, or prevent future non-compliance with Nasdaq listing requirements.
• If financial performance does not meet expectations or a prolonged decline occurs in the market price of common stock, it may cause a material change in goodwill impairment assessment and result in future impairment.
• Inability to obtain necessary additional financing on favorable terms, if needed, could require further reduction in sales, marketing, and product development efforts, adversely affecting financial condition and operating results.
• The indenture governing the 2029 Notes requires maintaining a minimum cash balance of $60.0 million, which could restrict liquidity.
• Ongoing governmental inquiries related to past COVID-19 products and services by Medicare, the Department of Justice, and the U.S. Food and Drug Administration could have an adverse impact.
• Pending stockholder litigation (Damri v. LivePerson, Inc.) and several derivative actions allege false and misleading disclosures, creating legal and financial uncertainty.
• Exposure to foreign currency exchange risks, which could impact financial results if not effectively mitigated.
• Collection risks on accounts receivable, despite established policies and practices, could lead to credit losses.
• Inflation risk could harm business, financial condition, and results of operations if higher costs cannot be fully offset through price increases.

Future Outlook

Management expects the 2025 restructuring activities to be substantially completed by the end of fiscal 2025. The company anticipates that current cash and cash equivalents will be sufficient to satisfy working capital and capital requirements for at least the next 12 months, but acknowledges that additional funds may be required for rapid expansion, new services or products, or acquisitions. The company is also evaluating the potential impact of recently issued accounting pronouncements on its future financial statements and disclosures.

Management Comments

• "We continue to observe heightened renewal hesitation and slower than anticipated new business bookings, primarily driven by customer uncertainty regarding our financial stability as well as broader macroeconomic factors extending enterprise buying cycles, especially for high-value AI solutions that require additional compliance approvals, with a corresponding impact on the Company's revenue."
• "While innovation remains a core component of our strategy, we are operating in a competitive environment characterized by aggressive investment in artificial intelligence and other technological innovation by competitors with significant resources and investment capital."
• "We anticipate that our current cash and cash equivalents will be sufficient to satisfy our working capital and capital requirements for at least the next 12 months."

Industry Context

LivePerson operates in the digital customer conversation platform industry, which is increasingly driven by artificial intelligence (AI) and Large Language Models (LLMs). The company notes a competitive environment with aggressive investment in AI by competitors possessing significant resources. Broader macroeconomic factors and customer uncertainty regarding LivePerson's financial stability are extending enterprise buying cycles for high-value AI solutions, impacting the company's revenue performance.

Comparison to Industry Standards

• Revenue retention for enterprise and mid-market customers was approximately 80% in the third quarter of 2025, which is significantly below the company's internal target range of 105% to 115%. This indicates underperformance relative to the company's own benchmarks, which are likely set with industry-leading retention rates in mind.

Corporate Governance

Legal Proceedings

• Stockholder class action (Damri v. LivePerson, Inc.) filed in December 2023, alleging false and misleading 2022 10-Q filings and forecasts. The court dismissed the action with prejudice in March 2025, but the plaintiff filed a notice of appeal in April 2025, which is pending.
• A parallel litigation (Weissbrod v. LivePerson, Inc.) is pending in the Tel Aviv District Court in Israel, stayed pending developments in the Damri case.
• Five purported derivative actions (Marti v. LoCascio, Steffens v. Block, Ravi v. LoCascio, Morales v. LoCascio, Perkins v. LoCascio) were filed between January and September 2024, claiming harm to the company from the same acts and omissions underlying the Damri lawsuit. These actions are stayed or in abeyance pending further developments in the Damri case.
• A lawsuit filed by Starboard Value LP in February 2024, alleging common law fraud, fraudulent inducement, and negligent misrepresentation, was settled in July 2025, with costs covered by insurance and no impact on the company's consolidated statements of operations.
• The company has discontinued all products and services related to COVID-19 but is cooperating with ongoing governmental inquiries from Medicare, the Department of Justice, and the U.S. Food and Drug Administration regarding its previous engagement in COVID-19 related offerings.

Stakeholder Impact

• Shareholders face potential negative impacts from continued revenue decline, poor customer retention, and the risk of delisting from Nasdaq, which would reduce share price, trading volume, and liquidity. The recent reverse stock split and equity issuance in the debt restructuring also impact their holdings.
• Employees are affected by ongoing restructuring initiatives, which involve headcount reductions and associated severance costs.
• Customers are exhibiting 'heightened renewal hesitation' and 'slower than anticipated new business bookings' due to uncertainty about the company's financial stability and broader macroeconomic factors, potentially impacting future service agreements.
• Creditors (noteholders) were directly impacted by the troubled debt restructuring, which altered the terms and nature of their investments, converting some debt into cash, new secured notes, common stock, and preferred stock.
• Regulatory bodies, including Nasdaq and various government agencies (Medicare, DOJ, FDA), are involved in monitoring the company's compliance with listing rules and investigating past business activities, requiring ongoing cooperation and potentially imposing future obligations.

Next Steps

• Substantially complete the 2025 restructuring activities by the end of fiscal 2025.
• Continue to cooperate with governmental inquiries related to previous COVID-19 product and service offerings.
• Monitor and potentially enter into financial instruments to mitigate foreign currency exchange risks.
• Evaluate the potential impact of adopting new accounting guidance (ASU 2025-06, 2025-05, 2024-03, 2023-09) on consolidated financial statements and disclosures.
• Address ongoing legal proceedings, including the appeal in the Damri case and the pending derivative actions.
• Maintain compliance with Nasdaq listing requirements, particularly the minimum bid price requirement, to avoid delisting.

Key Dates

Recommendation

The company faces significant operational and financial challenges, including a substantial decline in revenue, poor customer retention, and ongoing restructuring efforts that indicate fundamental business model issues. While a debt restructuring provided a one-time gain and reduced some debt, it involved issuing new, higher-interest debt and diluting equity. Negative cash flow from operations, declining cash reserves, and the necessity of a reverse stock split to maintain Nasdaq listing compliance signal deep financial instability. The competitive landscape, with aggressive AI investment from better-resourced competitors, further exacerbates the long-term outlook. Pending legal proceedings add additional uncertainty and potential liabilities. These factors collectively suggest a high-risk investment with a negative outlook, warranting a 'sell' recommendation.

Keywords

LivePerson, LPSN, Q3 2025, Quarterly Report, SEC filing, financial results, revenue, net income, debt restructuring, reverse stock split, Nasdaq compliance, AI, customer conversation platform, corporate governance, risk factors, financial stability, liquidity, capital resources, stock-based compensation, goodwill, intangible assets, legal proceedings, shareholder litigation, convertible notes, preferred stock, cash flow, operating activities, investing activities, financing activities, restructuring costs, ARPC, revenue retention